From Medscape Pulmonary Medicine

Coverage from the

American Thoracic Society (ATS) 2016 International Conference

May 13 - 18, 2016; San Francisco, California

May 13 - 18, 2016 San Francisco, California
  • ATS ACE Inhibitor Blunts Exercise Benefit in Pulmonary Rehab A second clinical trial assessing adjunct therapy with an ACE inhibitor for patients with COPD undergoing pulmonary rehabilitation confirmed the negative results of an earlier trial.
  • ATS Antibiotic Trial of Doxycycline Fails in COPD The role of antibiotics in COPD remains controversial, particularly for preventing future exacerbations in outpatients, and new results from a long-term randomized trial are adding to the debate.

Conference News

Popular News from ATS 2015

Medscape Pulmonary Medicine©  WebMD, LLC

Previous Coverage